Your browser doesn't support javascript.
loading
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis.
Rosenfeld, M; Gibson, R; McNamara, S; Emerson, J; McCoyd, K S; Shell, R; Borowitz, D; Konstan, M W; Retsch-Bogart, G; Wilmott, R W; Burns, J L; Vicini, P; Montgomery, A B; Ramsey, B.
Affiliation
  • Rosenfeld M; Division of Pulmonary Medicine, Children's Hospital and Regional Medical Center, Seattle, Washington 98105, USA.
J Pediatr ; 139(4): 572-7, 2001 Oct.
Article in En | MEDLINE | ID: mdl-11598606
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Respiratory Mucosa / Cystic Fibrosis / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Pediatr Year: 2001 Document type: Article Affiliation country: Country of publication:
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tobramycin / Respiratory Mucosa / Cystic Fibrosis / Anti-Bacterial Agents Type of study: Clinical_trials Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: J Pediatr Year: 2001 Document type: Article Affiliation country: Country of publication: